Since its establishment, with Tsinghua University, Chinese Academy of Medical Sciences and other scientific research institutions as the technical backing, Boao Bio is committed to developing and providing innovative products and services for the field of integrated healthcare (including predictive, preventive, and individualized healthcare), and has developed four series of biochips (including genes, proteins, cellular microarrays, and Lab-on-a-Chip, etc.) as well as related instrumentation, reagents and consumables, and software databases that can compete with other manufacturers in the international arena. We have developed dozens of products and services with independent intellectual property rights, which can compete with other manufacturers in the international arena, and many of our products have obtained certificates such as China Food and Drug Administration (SFDA) Medical Device Registration Certificate, European Union (EU) CE marking, and U.S. Food and Drug Administration (FDA) Safety Clearance Record. BioBio's products and services have been exported to more than 20 countries and regions in North America, Europe, Asia, and the Middle East, etc. Among them, nearly one hundred hospitals in European countries such as the UK, France, Germany, Italy, Spain, Denmark, Switzerland, and Sweden have purchased BioBio's microchip products, and have received favorable feedbacks from users.